INS and neoplasm: The mechanism of anticarcinogenic may attribute to that the metformin prompt release of Adenosine 5′-monophosphate– (AMP–) activated protein kinase (AMPK) so that it can inhibit of tumor cellular protein's synthesis and increase, with low level of insulin [66, 67].